BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10644022)

  • 1. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of corticosteroid patch test preparations.
    Isaksson M; Gruvberger B; Persson L; Bruze M
    Contact Dermatitis; 2000 Mar; 42(3):144-8. PubMed ID: 10727164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of patch testing with a corticosteroid at a low concentration.
    Isaksson M; Bruze M; Björkner B; Hindsén M; Svensson L
    Am J Contact Dermat; 1999 Mar; 10(1):31-3. PubMed ID: 10072336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis.
    Isaksson M; Brandão FM; Bruze M; Goossens A
    Contact Dermatitis; 2000 Jul; 43(1):41-2. PubMed ID: 10902588
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for corticosteroid contact hypersensitivity.
    Boffa MJ; Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Sep; 33(3):149-51. PubMed ID: 8565453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 14. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing for corticosteroid allergy using high and low concentrations.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 2000 Jun; 42(6):350-1. PubMed ID: 10871100
    [No Abstract]   [Full Text] [Related]  

  • 18. Contact hypersensitivity to epoxy resin, methyldibromoglutaronitrile, tixocortol pivalate and budesonide in Hungary: a study in 1448 patients.
    Pónyai G; Németh I; Husz S; Jurcsik A; Nebenführer L; Dinnyés M; Némethy P; Kohánka V; Temesvári E
    G Ital Dermatol Venereol; 2011 Feb; 146(1):53-6. PubMed ID: 21317857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid contact allergy: an EECDRG multicentre study.
    Dooms-Goossens A; Andersen KE; Brandäo FM; Bruynzeel D; Burrows D; Camarasa J; Ducombs G; Frosch P; Hannuksela M; Lachapelle JM; Lahti A; Menné T; Wahlberg JE; Wilkinson JD
    Contact Dermatitis; 1996 Jul; 35(1):40-4. PubMed ID: 8896953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroids.
    Isaksson M
    Dermatol Ther; 2004; 17(4):314-20. PubMed ID: 15327476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.